<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Recent studies have identified <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> as a risk factor for both recurrent pregnancy loss and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e>, an <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e>, is also characterized by recurrent pregnancy loss and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, our purpose was to determine if <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> is more common in patients with APS than <z:mpath ids='MPATH_458'>normal</z:mpath> fertile controls </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Plasma, sera and whole blood were obtained from two groups of women: (1) 22 with well-characterized <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>; and (2) 41 healthy fertile controls </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of fasting <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, vitamin B16, <z:chebi fb="9" ids="17439">vitamin B12</z:chebi>, <z:chebi fb="3" ids="37445">folate</z:chebi> and the incidence of the C677/T mutation of the <z:chebi fb="13" ids="29357,29358">methylene</z:chebi> <z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase genotype (C677T/MTHFR) were determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The proportion of individuals with <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> and fasting plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels were similar in women with APS and controls </plain></SENT>
<SENT sid="6" pm="."><plain>Levels of <z:chebi fb="14" ids="27306">vitamin B6</z:chebi>, <z:chebi fb="9" ids="17439">vitamin B12</z:chebi>, <z:chebi fb="3" ids="37445">folate</z:chebi> and the incidence of C677/MTHFR were also similar in the two groups </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Hyperhomocyteinemia and the C677T/MTHFR mutation are not common in women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Abnormal <z:chebi fb="0" ids="17230">homocysteine</z:chebi> metabolism is unlikely to play a major role in the pathogenesis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>